Diligence memo · auto-generated · as of July 2, 2026

Seashore Surgical Institute, L.L.C.

Seashore Surgical Institute, L.L.C. looks over-valued against its niche peers and is at-risk on financing cadence.

WatchOverdue for a raise versus sector cadence — could be a bridge, a down round, or distress. Watch for the next filing.

Businessfiled

Seashore Surgical Institute, L.L.C. operates in Medical Devices, based in BRICK.

Sub-sector tags: medical-devices.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Seashore Surgical Institute, L.L.C. has raised $1.4M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).

Largest single filing: $780K on 2022-06-27.

Most recent recorded round closed around 2022-06-27.

Valuation (modeled)modeled

Provath models Seashore Surgical Institute, L.L.C. at approximately $10.0M (range $468K–$62M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Over-valued. Modeled value is 3.55× the median modeled value of Pre-Seed Medical Devices companies in 2022–2024 (29 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Historic cadence: a new round about every 16 months.

Last raise 4.0 yr ago; this sector typically re-raises about every 16 months.

Past due for a raise versus sector cadence — watch for distress or a bridge.

The last round stepped up 4.4× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 46% of Medical Devices peers (233 compared).

Modeled value ranks above 51% of those peers.

Closest niche peers: Turbett Surgical, Inc., Owensboro Ambulatory Surgical Facility Ltd, Hera Diagnostics Corp, Hawkeye Surgical Lighting, LIBERTAS Implant Solutions, LLC.

Peoplefiled

13 named people on file across officers, directors and signatories.

Risks & flagsmixed

Overdue for a raise versus sector norm — distress or bridge risk.

Modeled above niche peers — valuation risk on entry.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.